{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T01:35:46Z","timestamp":1792892146256,"version":"4.5.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,28]]},"DOI":"10.7759\/cureus.106013","type":"journal-article","created":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T07:37:54Z","timestamp":1774683474000},"source":"Crossref","is-referenced-by-count":2,"title":["Shared Pathophysiology and Early Detection Biomarkers in Endometriosis and Polycystic Ovary Syndrome (PCOS): Opportunities for AI-Enabled Screening"],"prefix":"10.7759","author":[{"given":"Shubham","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anushree","family":".","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goter","family":"Doke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devyani","family":"Misra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish Kumar","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Honey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1324429","article-title":"Chronic low-grade inflammation and ovarian dysfunction in women with polycystic ovarian syndrome, endometriosis, and aging","volume":"14","author":"Orisaka M","year":"2023","unstructured":"Orisaka M, Mizutani T, Miyazaki Y, et al.. Chronic low-grade inflammation and ovarian dysfunction in women with polycystic ovarian syndrome, endometriosis, and aging. Front Endocrinol (Lausanne). 2023, 14:1324429. 10.3389\/fendo.2023.1324429","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2022.103852","article-title":"The epigenetic correlation among ovarian cancer, endometriosis and PCOS: a review","volume":"180","author":"Throwba H PK","year":"2022","unstructured":"Throwba H PK, Unnikrishnan L, Pangath M, et al.. The epigenetic correlation among ovarian cancer, endometriosis and PCOS: a review. Crit Rev Oncol Hematol. 2022, 180:103852. 10.1016\/j.critrevonc.2022.103852","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/nu13041178","article-title":"Nutrition in gynecological diseases: current perspectives","volume":"13","author":"Ciebiera M","year":"2021","unstructured":"Ciebiera M, Esfandyari S, Siblini H, et al.. Nutrition in gynecological diseases: current perspectives. Nutrients. 2021, 13:1178. 10.3390\/nu13041178","journal-title":"Nutrients"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1186\/s12884-024-06590-0","article-title":"Association of vitamin D receptor genetic polymorphisms with the risk of infertility: a systematic review and meta-analysis","volume":"24","author":"Moradkhani A","year":"2024","unstructured":"Moradkhani A, Azami M, Assadi S, Ghaderi M, Azarnezhad A, Moradi Y. Association of vitamin D receptor genetic polymorphisms with the risk of infertility: a systematic review and meta-analysis. BMC Pregnancy Childbirth. 2024, 24:398. 10.1186\/s12884-024-06590-0","journal-title":"BMC Pregnancy Childbirth"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115415","article-title":"The emerging role of ferroptosis in female reproductive disorders","volume":"166","author":"Liu M","year":"2023","unstructured":"Liu M, Wu K, Wu Y. The emerging role of ferroptosis in female reproductive disorders. Biomed Pharmacother. 2023, 166:115415. 10.1016\/j.biopha.2023.115415","journal-title":"Biomed Pharmacother"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/cells11040647","article-title":"Progesterone actions and resistance in gynecological disorders","volume":"11","author":"MacLean JA 2nd","year":"2022","unstructured":"MacLean JA 2nd, Hayashi K. Progesterone actions and resistance in gynecological disorders. Cells. 2022, 11:647. 10.3390\/cells11040647","journal-title":"Cells"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.1059825","article-title":"Gut and genital tract microbiomes: dysbiosis and link to gynecological disorders","volume":"12","author":"Elkafas H","year":"2022","unstructured":"Elkafas H, Walls M, Al-Hendy A, Ismail N. Gut and genital tract microbiomes: dysbiosis and link to gynecological disorders. Front Cell Infect Microbiol. 2022, 12:1059825. 10.3389\/fcimb.2022.1059825","journal-title":"Front Cell Infect Microbiol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2021.1894070","article-title":"The impact of the gut microbiota on the reproductive and metabolic endocrine system","volume":"13","author":"Qi X","year":"2021","unstructured":"Qi X, Yun C, Pang Y, Qiao J. The impact of the gut microbiota on the reproductive and metabolic endocrine system. Gut Microbes. 2021, 13:1-21. 10.1080\/19490976.2021.1894070","journal-title":"Gut Microbes"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1530\/JME-21-0238","article-title":"Female reproductive dysfunctions and the gut microbiota","volume":"69","author":"Chadchan SB","year":"2022","unstructured":"Chadchan SB, Singh V, Kommagani R. Female reproductive dysfunctions and the gut microbiota. J Mol Endocrinol. 2022, 69:R81-94. 10.1530\/JME-21-0238","journal-title":"J Mol Endocrinol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_202101_24412","article-title":"The use of D-chiro-Inositol in clinical practice","volume":"25","author":"Gambioli R","year":"2021","unstructured":"Gambioli R, Forte G, Aragona C, Bevilacqua A, Bizzarri M, Unfer V. The use of D-chiro-Inositol in clinical practice. Eur Rev Med Pharmacol Sci. 2021, 25:438-46. 10.26355\/eurrev_202101_24412","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3390\/nu12082464","article-title":"The role of zinc in selected female reproductive system disorders","volume":"12","author":"Nasiadek M","year":"2020","unstructured":"Nasiadek M, Stragierowicz J, Klimczak M, Kilanowicz A. The role of zinc in selected female reproductive system disorders. Nutrients. 2020, 12:2464. 10.3390\/nu12082464","journal-title":"Nutrients"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmac031","article-title":"Biomechanical forces and signals operating in the ovary during folliculogenesis and their dysregulation: implications for fertility","volume":"29","author":"Fiorentino G","year":"2023","unstructured":"Fiorentino G, Cimadomo D, Innocenti F, et al.. Biomechanical forces and signals operating in the ovary during folliculogenesis and their dysregulation: implications for fertility. Hum Reprod Update. 2023, 29:1-23. 10.1093\/humupd\/dmac031","journal-title":"Hum Reprod Update"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3390\/nu13093126","article-title":"Potential health benefits of curcumin on female reproductive disorders: a review","volume":"13","author":"Kamal DA","year":"2021","unstructured":"Kamal DA, Salamt N, Yusuf AN, Kashim MI, Mokhtar MH. Potential health benefits of curcumin on female reproductive disorders: a review. Nutrients. 2021, 13:3126. 10.3390\/nu13093126","journal-title":"Nutrients"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1186\/s13048-024-01480-7","article-title":"Extracellular vesicles and their content in the context of polycystic ovarian syndrome and endometriosis: a review","volume":"17","author":"Duval C","year":"2024","unstructured":"Duval C, Wyse BA, Tsang BK, Librach CL. Extracellular vesicles and their content in the context of polycystic ovarian syndrome and endometriosis: a review. J Ovarian Res. 2024, 17:160. 10.1186\/s13048-024-01480-7","journal-title":"J Ovarian Res"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.55240","article-title":"Ayurvedic herbal medicines: a literature review of their applications in female reproductive health","volume":"16","author":"Patibandla S","year":"2024","unstructured":"Patibandla S, Gallagher JJ, Patibandla L, Ansari AZ, Qazi S, Brown SF. Ayurvedic herbal medicines: a literature review of their applications in female reproductive health. Cureus. 2024, 16:e55240. 10.7759\/cureus.55240","journal-title":"Cureus"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3390\/cells9102253","article-title":"Mesenchymal stem cells as a bio organ for treatment of female infertility","volume":"9","author":"Esfandyari S","year":"2020","unstructured":"Esfandyari S, Chugh RM, Park HS, Hobeika E, Ulin M, Al-Hendy A. Mesenchymal stem cells as a bio organ for treatment of female infertility. Cells. 2020, 9:2253. 10.3390\/cells9102253","journal-title":"Cells"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.envint.2021.106819","article-title":"Perfluoroalkyl substances (PFAS) in drinking water and risk for polycystic ovarian syndrome, uterine leiomyoma, and endometriosis: a Swedish cohort study","volume":"157","author":"Hammarstrand S","year":"2021","unstructured":"Hammarstrand S, Jakobsson K, Andersson E, Xu Y, Li Y, Olovsson M, Andersson EM. Perfluoroalkyl substances (PFAS) in drinking water and risk for polycystic ovarian syndrome, uterine leiomyoma, and endometriosis: a Swedish cohort study. Environ Int. 2021, 157:106819. 10.1016\/j.envint.2021.106819","journal-title":"Environ Int"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/eva.13244","article-title":"Endometriosis and polycystic ovary syndrome are diametric disorders","volume":"14","author":"Dinsdale NL","year":"2021","unstructured":"Dinsdale NL, Crespi BJ. Endometriosis and polycystic ovary syndrome are diametric disorders. Evol Appl. 2021, 14:1693-715. 10.1111\/eva.13244","journal-title":"Evol Appl"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1093\/narmme\/ugae010","article-title":"The role of RAD51 regulators and variants in primary ovarian insufficiency, endometriosis,\u00a0and polycystic ovary syndrome","volume":"1","author":"Witham M","year":"2024","unstructured":"Witham M, Hengel SR. The role of RAD51 regulators and variants in primary ovarian insufficiency, endometriosis,\u00a0and polycystic ovary syndrome. NAR Mol Med. 2024, 1:ugae010. 10.1093\/narmme\/ugae010","journal-title":"NAR Mol Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26052256","article-title":"Vitamin D in reproductive health disorders: a narrative review focusing on infertility, endometriosis, and polycystic ovarian syndrome","volume":"26","author":"van Tienhoven XA","year":"2025","unstructured":"van Tienhoven XA, Ruiz de Ch\u00e1vez Gasc\u00f3n J, Cano-Herrera G, et al.. Vitamin D in reproductive health disorders: a narrative review focusing on infertility, endometriosis, and polycystic ovarian syndrome. Int J Mol Sci. 2025, 26:2256. 10.3390\/ijms26052256","journal-title":"Int J Mol Sci"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1530\/EC-23-0431","article-title":"Endometriosis, polycystic ovary syndrome, and the thyroid: a review","volume":"13","author":"Kirkegaard S","year":"2024","unstructured":"Kirkegaard S, Uldall Torp NM, Andersen S, Andersen SL. Endometriosis, polycystic ovary syndrome, and the thyroid: a review. Endocr Connect. 2024, 13:230431. 10.1530\/EC-23-0431","journal-title":"Endocr Connect"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241814126","article-title":"Polycystic ovary syndrome and oxidative stress\u2014from bench to bedside","volume":"24","author":"Zeber-Lubecka N","year":"2023","unstructured":"Zeber-Lubecka N, Ciebiera M, Hennig EE. Polycystic ovary syndrome and oxidative stress\u2014from bench to bedside. Int J Mol Sci. 2023, 24:14126. 10.3390\/ijms241814126","journal-title":"Int J Mol Sci"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1359236","article-title":"Dissecting the shared genetic architecture between endometriosis and polycystic ovary syndrome","volume":"15","author":"Tan H","year":"2024","unstructured":"Tan H, Long P, Xiao H. Dissecting the shared genetic architecture between endometriosis and polycystic ovary syndrome. Front Endocrinol (Lausanne). 2024, 15:1359236. 10.3389\/fendo.2024.1359236","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1080\/09513590.2018.1534096","article-title":"Altered leptin, adiponectin, resistin and ghrelin secretion may represent an intrinsic polycystic ovary syndrome abnormality","volume":"35","author":"Baldani DP","year":"2019","unstructured":"Baldani DP, Skrgatic L, Kasum M, Zlopasa G, Kralik Oguic S, Herman M. Altered leptin, adiponectin, resistin and ghrelin secretion may represent an intrinsic polycystic ovary syndrome abnormality. Gynecol Endocrinol. 2019, 35:401-5. 10.1080\/09513590.2018.1534096","journal-title":"Gynecol Endocrinol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-025-22881-3","article-title":"The global burden of polycystic ovary syndrome, endometriosis, uterine fibroids, cervical cancer, uterine cancer, and ovarian cancer from 1990 to 2021","volume":"25","author":"Tang WZ","year":"2025","unstructured":"Tang WZ, Cai QY, Huang KJ, et al.. The global burden of polycystic ovary syndrome, endometriosis, uterine fibroids, cervical cancer, uterine cancer, and ovarian cancer from 1990 to 2021. BMC Public Health. 2025, 25:1774. 10.1186\/s12889-025-22881-3","journal-title":"BMC Public Health"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10102503","article-title":"The complex roles of adipokines in polycystic ovary syndrome and endometriosis","volume":"10","author":"Sch\u00fcler-Toprak S","year":"2022","unstructured":"Sch\u00fcler-Toprak S, Ortmann O, Buechler C, Treeck O. The complex roles of adipokines in polycystic ovary syndrome and endometriosis. Biomedicines. 2022, 10:2503. 10.3390\/biomedicines10102503","journal-title":"Biomedicines"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10071705","article-title":"Sex steroid receptors in polycystic ovary syndrome and endometriosis: insights from laboratory studies to clinical trials","volume":"10","author":"Abdul Hamid F","year":"2022","unstructured":"Abdul Hamid F, Abu MA, Abdul Karim AK, Ahmad MF, Abd Aziz NH, Mohd Kamal DA, Mokhtar MH. Sex steroid receptors in polycystic ovary syndrome and endometriosis: insights from laboratory studies to clinical trials. Biomedicines. 2022, 10:1705. 10.3390\/biomedicines10071705","journal-title":"Biomedicines"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2023.166704","article-title":"CXC chemokines influence immune surveillance in immunological disorders: polycystic ovary syndrome and endometriosis","volume":"1869","author":"Ullah A","year":"2023","unstructured":"Ullah A, Wang MJ, Wang YX, Shen B. CXC chemokines influence immune surveillance in immunological disorders: polycystic ovary syndrome and endometriosis. Biochim Biophys Acta Mol Basis Dis. 2023, 1869:166704. 10.1016\/j.bbadis.2023.166704","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2010.01.049","article-title":"Reduced percentage of natural killer cells associated with impaired cytokine network in the secretory endometrium of infertile women with polycystic ovary syndrome","volume":"94","author":"Matteo M","year":"2010","unstructured":"Matteo M, Serviddio G, Massenzio F, et al.. Reduced percentage of natural killer cells associated with impaired cytokine network in the secretory endometrium of infertile women with polycystic ovary syndrome. Fertil Steril. 2010, 94:2222-7, 2227.e1-3. 10.1016\/j.fertnstert.2010.01.049","journal-title":"Fertil Steril"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1093\/emph\/eoab029","article-title":"Variation among human populations in endometriosis and PCOS A test of the inverse comorbidity model","volume":"9","author":"Crespi B","year":"2021","unstructured":"Crespi B. Variation among human populations in endometriosis and PCOS A test of the inverse comorbidity model. Evol Med Public Health. 2021, 9:295-310. 10.1093\/emph\/eoab029","journal-title":"Evol Med Public Health"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.2196\/65469","article-title":"Exploring self-reported symptoms for developing and evaluating digital symptom checkers for polycystic ovarian syndrome, endometriosis, and uterine fibroids: exploratory survey study","volume":"8","author":"Wickham AP","year":"2024","unstructured":"Wickham AP, Hewings-Martin Y, Goddard FG, et al.. Exploring self-reported symptoms for developing and evaluating digital symptom checkers for polycystic ovarian syndrome, endometriosis, and uterine fibroids: exploratory survey study. JMIR Form Res. 2024, 8:e65469. 10.2196\/65469","journal-title":"JMIR Form Res"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jogoh.2023.102603","article-title":"Short review on adverse childhood experiences, pelvic pain and endometriosis","volume":"52","author":"Moussaoui D","year":"2023","unstructured":"Moussaoui D, Joseph K, Grover SR. Short review on adverse childhood experiences, pelvic pain and endometriosis. J Gynecol Obstet Hum Reprod. 2023, 52:102603. 10.1016\/j.jogoh.2023.102603","journal-title":"J Gynecol Obstet Hum Reprod"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph18041442","article-title":"Polycystic ovary syndrome and endometriosis as reasons for women\u2019s admission to outpatient specialist care in poland\u2014a retrospective analysis","volume":"18","author":"Rzo\u0144ca E","year":"2021","unstructured":"Rzo\u0144ca E, Kosowski A, Bie\u0144 A, et al.. Polycystic ovary syndrome and endometriosis as reasons for women\u2019s admission to outpatient specialist care in poland\u2014a retrospective analysis. Int J Environ Res Public Health. 2021, 18:1442. 10.3390\/ijerph18041442","journal-title":"Int J Environ Res Public Health"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.696879","article-title":"A systematic review of anogenital distance and gynecological disorders: endometriosis and polycystic ovary syndrome","volume":"12","author":"Pan Z","year":"2021","unstructured":"Pan Z, Zhu F, Zhou K. A systematic review of anogenital distance and gynecological disorders: endometriosis and polycystic ovary syndrome. Front Endocrinol (Lausanne). 2021, 12:696879. 10.3389\/fendo.2021.696879","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deac210","article-title":"Polycystic ovary syndrome and risk of adverse pregnancy outcomes: a registry linkage study from Massachusetts","volume":"37","author":"Farland LV","year":"2022","unstructured":"Farland LV, Stern JE, Liu CL, et al.. Polycystic ovary syndrome and risk of adverse pregnancy outcomes: a registry linkage study from Massachusetts. Hum Reprod. 2022, 37:2690-9. 10.1093\/humrep\/deac210","journal-title":"Hum Reprod"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2022.02.009","article-title":"Assisted reproductive technology treatment increases obstetric and neonatal risks over that of the underlying infertility diagnosis","volume":"117","author":"Stern JE","year":"2022","unstructured":"Stern JE, Liu CL, Cui X, Cabral HJ, Farland LV, Coddington C, Diop H. Assisted reproductive technology treatment increases obstetric and neonatal risks over that of the underlying infertility diagnosis. Fertil Steril. 2022, 117:1223-34. 10.1016\/j.fertnstert.2022.02.009","journal-title":"Fertil Steril"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.78222","article-title":"Reproductive endocrine disorders: a comprehensive guide to the diagnosis and management of infertility, polycystic ovary syndrome, and endometriosis","volume":"17","author":"Saleem Azam S","year":"2025","unstructured":"Saleem Azam S, Vasudevan S, Saqib Bukhari W, et al.. Reproductive endocrine disorders: a comprehensive guide to the diagnosis and management of infertility, polycystic ovary syndrome, and endometriosis. Cureus. 2025, 17:e78222. 10.7759\/cureus.78222","journal-title":"Cureus"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1093\/emph\/eoab008","article-title":"The evolutionary biology of endometriosis","volume":"9","author":"Dinsdale N","year":"2021","unstructured":"Dinsdale N, Nepomnaschy P, Crespi B. The evolutionary biology of endometriosis. Evol Med Public Health. 2021, 9:174-91. 10.1093\/emph\/eoab008","journal-title":"Evol Med Public Health"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.5468\/ogs.23193","article-title":"A glance into the roles of microRNAs (exosomal and non-exosomal) in polycystic ovary syndrome","volume":"67","author":"Chelegahi AM","year":"2024","unstructured":"Chelegahi AM, Ebrahimi SO, Reiisi S, Nezamnia M. A glance into the roles of microRNAs (exosomal and non-exosomal) in polycystic ovary syndrome. Obstet Gynecol Sci. 2024, 67:30-48. 10.5468\/ogs.23193","journal-title":"Obstet Gynecol Sci"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1097\/CAD.0000000000001405","article-title":"CDKN2B-AS1 is overexpressed in polycystic ovary syndrome and sponges miR-181a to promote granulosa cell proliferation","volume":"34","author":"Huang Y","year":"2023","unstructured":"Huang Y, Zhang Y, Zhou Y, Chen Y, Zhu Q. CDKN2B-AS1 is overexpressed in polycystic ovary syndrome and sponges miR-181a to promote granulosa cell proliferation. Anticancer Drugs. 2023, 34:207-13. 10.1097\/CAD.0000000000001405","journal-title":"Anticancer Drugs"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1016\/S2589-7500(23)00153-X","article-title":"Artificial intelligence for breast cancer detection in screening mammography in Sweden: a prospective, population-based, paired-reader, non-inferiority study","volume":"5","author":"Dembrower K","year":"2023","unstructured":"Dembrower K, Crippa A, Col\u00f3n E, Eklund M, Strand F. Artificial intelligence for breast cancer detection in screening mammography in Sweden: a prospective, population-based, paired-reader, non-inferiority study. Lancet Digit Health. 2023, 5:703-11. 10.1016\/S2589-7500(23)00153-X","journal-title":"Lancet Digit Health"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2022.12.016","article-title":"Electrocardiogram detection of pulmonary hypertension using deep learning","volume":"29","author":"Aras MA","year":"2023","unstructured":"Aras MA, Abreau S, Mills H, et al.. Electrocardiogram detection of pulmonary hypertension using deep learning. J Card Fail. 2023, 29:1017-28. 10.1016\/j.cardfail.2022.12.016","journal-title":"J Card Fail"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101666","article-title":"Transformer-based AI technology improves early ovarian cancer diagnosis using cfDNA methylation markers","volume":"5","author":"Li G","year":"2024","unstructured":"Li G, Zhang Y, Li K, et al.. Transformer-based AI technology improves early ovarian cancer diagnosis using cfDNA methylation markers. Cell Rep Med. 2024, 5:101666. 10.1016\/j.xcrm.2024.101666","journal-title":"Cell Rep Med"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1002\/cnr2.70016","article-title":"Prostate cancer: a review of genetics, current biomarkers and personalised treatments","volume":"7","author":"Wilson TK","year":"2024","unstructured":"Wilson TK, Zishiri OT. Prostate cancer: a review of genetics, current biomarkers and personalised treatments. Cancer Rep (Hoboken). 2024, 7:e70016. 10.1002\/cnr2.70016","journal-title":"Cancer Rep (Hoboken)"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1016\/j.pccm.2023.05.001","article-title":"Novel tools for early diagnosis and precision treatment based on artificial intelligence","volume":"1","author":"Shao J","year":"2023","unstructured":"Shao J, Feng J, Li J, Liang S, Li W, Wang C. Novel tools for early diagnosis and precision treatment based on artificial intelligence. Chin Med J Pulm Crit Care Med. 2023, 1:148-60. 10.1016\/j.pccm.2023.05.001","journal-title":"Chin Med J Pulm Crit Care Med"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2023.189026","article-title":"Artificial intelligence and allied subsets in early detection and preclusion of gynecological cancers","volume":"1878","author":"Garg P","year":"2023","unstructured":"Garg P, Mohanty A, Ramisetty S, et al.. Artificial intelligence and allied subsets in early detection and preclusion of gynecological cancers. Biochim Biophys Acta Rev Cancer. 2023, 1878:189026. 10.1016\/j.bbcan.2023.189026","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2023.1102185","article-title":"The use of artificial intelligence for delivery of essential health services across WHO regions: a scoping review","volume":"11","author":"Okeibunor JC","year":"2023","unstructured":"Okeibunor JC, Jaca A, Iwu-Jaja CJ, et al.. The use of artificial intelligence for delivery of essential health services across WHO regions: a scoping review. Front Public Health. 2023, 11:1102185. 10.3389\/fpubh.2023.1102185","journal-title":"Front Public Health"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0306991","article-title":"Global burden and epidemiological prediction of polycystic ovary syndrome from 1990 to 2019: a systematic analysis from the Global Burden of Disease Study 2019","volume":"19","author":"Zhang J","year":"2024","unstructured":"Zhang J, Zhu Y, Wang J, et al.. Global burden and epidemiological prediction of polycystic ovary syndrome from 1990 to 2019: a systematic analysis from the Global Burden of Disease Study 2019. PLoS One. 2024, 19:e0306991. 10.1371\/journal.pone.0306991","journal-title":"PLoS One"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1530\/EC-24-0522","article-title":"Establishment of critical values for AMH screening with PCOS based on restricted cubic spline plots","volume":"14","author":"Wang Z","year":"2025","unstructured":"Wang Z, Teng X, Shen Y, Liu Y. Establishment of critical values for AMH screening with PCOS based on restricted cubic spline plots. Endocr Connect. 2025, 14:240522. 10.1530\/EC-24-0522","journal-title":"Endocr Connect"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1089\/jwh.2023.0741","article-title":"Risk factors for incident polycystic ovary syndrome diagnosis","volume":"33","author":"Christ JP","year":"2024","unstructured":"Christ JP, Yu O, Barton B, et al.. Risk factors for incident polycystic ovary syndrome diagnosis. J Womens Health (Larchmt). 2024, 33:879-86. 10.1089\/jwh.2023.0741","journal-title":"J Womens Health (Larchmt)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/469145-shared-pathophysiology-and-early-detection-biomarkers-in-endometriosis-and-polycystic-ovary-syndrome-pcos-opportunities-for-ai-enabled-screening","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T07:37:55Z","timestamp":1774683475000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/469145-shared-pathophysiology-and-early-detection-biomarkers-in-endometriosis-and-polycystic-ovary-syndrome-pcos-opportunities-for-ai-enabled-screening"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,28]]},"references-count":50,"URL":"https:\/\/doi.org\/10.7759\/cureus.106013","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,28]]}}}